تقرير
أعرض في EDS

Primary Cutaneous Diffuse Large B-Cell Lymphoma of the Upper Limb: Double Hit/Double Expressor with CNS Involvement: From Hospice to Remission.

التفاصيل البيبلوغرافية
العنوان: Primary Cutaneous Diffuse Large B-Cell Lymphoma of the Upper Limb: Double Hit/Double Expressor with CNS Involvement: From Hospice to Remission.
المؤلفون: Castillo BS; Texas Tech University Health Sciences Center Paul L. Foster School of Medicine, El Paso, Texas, USA., Rodriguez ML; Brown University, Providence, RI, USA., John Chao JH; Methodist Hospital, Texas Transplant Institute, San Antonio, Texas, USA., Zoghi B; Methodist Hospital, Texas Transplant Institute, San Antonio, Texas, USA.
المصدر: Case reports in hematology [Case Rep Hematol] 2019 Feb 07; Vol. 2019, pp. 3953470. Date of Electronic Publication: 2019 Feb 07 (Print Publication: 2019).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 101576456 Publication Model: eCollection Cited Medium: Print ISSN: 2090-6560 (Print) Linking ISSN: 20906579 NLM ISO Abbreviation: Case Rep Hematol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Hindawi Pub. Corp.
مستخلص: We report a patient with diffuse large B-cell lymphoma of skin, nongerminal center type double hit double expressor, with an initial presentation as a left forearm mass. The patient underwent chemotherapy after initial diagnosis. After chemotherapy regimen, she developed a second mass, followed by CNS involvement with neurological defects. At this time, a three line of chemotherapy was used with minimal effects. The patient was deemed terminal and was recommended hospice care. The patient decided to continue with skin and crainospinal radiotherapy and intrathecal chemotherapy; she achieved complete remission. After achieving complete remission, the patient underwent an autologous stem cell transplant with minimal transplant-related toxicity.
References: J Clin Oncol. 2012 Oct 1;30(28):3452-9. (PMID: 22851565)
Indian J Dermatol. 2013 Sep;58(5):366-8. (PMID: 24082181)
J Investig Med High Impact Case Rep. 2016 Apr 08;4(2):2324709616642592. (PMID: 27115017)
Oncologist. 2016 Sep;21(9):1107-12. (PMID: 27382029)
Blood Rev. 2017 Mar;31(2):37-42. (PMID: 27717585)
Blood. 2018 May 3;131(18):2060-2064. (PMID: 29475959)
تواريخ الأحداث: Date Created: 20190319 Latest Revision: 20201001
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC6383425
DOI: 10.1155/2019/3953470
PMID: 30881709
قاعدة البيانات: MEDLINE
الوصف
تدمد:2090-6560
DOI:10.1155/2019/3953470